Molecular mechanisms regulating cardiac fibroblast behaviour
Research type
Research Study
Full title
Molecular Mechanisms regulating cardiac fibroblast proliferation
IRAS ID
282301
Contact name
Mark Bond
Contact email
Sponsor organisation
University of Bristol
Duration of Study in the UK
3 years, 0 months, 1 days
Research summary
Cardiac fibrosis is the main pathophysiological processes contributing to heart failure. Excessive ECM production and increased proliferation of cardiac fibroblasts contributes towards cardiac fibrosis, which increases myocardium stiffness, causing systolic/diastolic cardiac dysfunction and ultimately heart failure. Unfortunately, current treatment options are only partially effective. Hence a better understanding of the underlying mechanisms is required to help develop novel therapies. Our research will study the mechanisms controlling the growth and migration of cardiac fibroblasts, with the aim of identifying new therapies to reduce cardiac fibrosis.
REC name
South West - Frenchay Research Ethics Committee
REC reference
22/SW/0128
Date of REC Opinion
15 Sep 2022
REC opinion
Favourable Opinion